General Statement of Disclosure: CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(MODEST), Medtronic(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Zoll (MODEST) View Full Disclosure